T. Rowe Price Associates’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
VCM
RIM
ETC
AIC
T. Rowe Price Associates's ASPI Position: Q1 2026 in Review
T. Rowe Price Associates increased its ASP Isotopes (ASPI) stake by 64% in Q1 2026, buying an estimated $187K and bringing the position to 80,641 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.
T. Rowe Price Associates first reported a position in ASPI in Q2 2024 and has held it in 8 quarters since. The position peaked at $10.1M in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.
- T. Rowe Price Associates held 80,641 shares of ASP Isotopes worth $357K as of Q1 2026.
- T. Rowe Price Associates bought 31,597 ASP Isotopes shares in Q1 2026, an estimated $187K.
- ASP Isotopes made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2597 holding.
- T. Rowe Price Associates first reported a position in ASP Isotopes in Q2 2024 and has held it in 8 quarters since.
- T. Rowe Price Associates's ASP Isotopes position peaked at $10.1M in Q3 2025.
- 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.